Switching from tirzepatide to semaglutide or switching to retatrutide are options worth discussing with your provider based on your specific goals and response patterns
Individualized treatment plans created around your lifestyle and health history Virtual appointments to discuss symptoms, goals, and treatment options GLP-1 medications (when appropriate) like Mounjaro and Ozempic Ongoing follow-up to ensure your care plan evolves with your needs Whether youre dealing with weight-related health issues or simply ready to take a new approach, our care is rooted in science, empathy, and accessibility
Heres how I break it down: 1
The Drugs.com JMIR sample captured a more frustrated version: "It has done absolutely NOTHING for me for weight loss." This is the camp the STEP 1 trial captures too, roughly 13.6 percent of participants on semaglutide failed to hit the 5 percent weight loss threshold by week 68
UK guidance on managing GLP-1 medications around surgery is evolving as clinical experience with these agents increases
Suggesting that the C-terminal sequence differences between exendin-4 and lixisenatide might impact on these cellular processes, a limited evaluation in our earlier study implied that lixisenatide displays reduced signalling potency and insulinotropism compared to exendin-4 (Jones et al., 2018b)
,aspect=ignore)
